147 results on '"Le Bras, F."'
Search Results
2. CD30 as a therapeutic target in adult haematological malignancies: Where are we now?
3. Real-life evaluation of an algorithm for the diagnosis of cardiac amyloidosis
4. S210: CAR T-CELLS ASSOCIATED ACUTE TOXICITY IN B-CELL NON-HODGKIN LYMPHOMA: REAL-WORLD STUDY FROM THE DESCAR-T REGISTRY
5. Don't Judge a Book by its Cover. ‘Steroid Acne’: an unrecognized role of Malassezia and Demodex?
6. Development of a Questionnaire for the Search for Occupational Causes in Patients with Non-Hodgkin Lymphoma: The RHELYPRO Study
7. 817TiP GYNET study - Safety and efficacy of anti-netrin 1 (NP137) in combination with chemotherapy and/or pembrolizumab in patients (pts) with pretreated locally advanced/metastatic endometrial carcinoma or cervix carcinoma: An adaptive multi-arms randomized phase I/II trial
8. Corrigendum to ‘Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers’
9. Prevalence and type of first amyloid extracardiac symptoms and cardiac disorders history and time from their occurrence to diagnosis between Al and transthyretin cardiac amyloidosis
10. « Acné » cortico-induite : rôle prépondérant de Malassezia et de Demodex ?
11. Transfusion needs after CD19 CAR T‐cells for large B‐cell lymphoma: predictive factors and impact on outcome. A DESCAR‐T study.
12. PROGNOSTIC SCORING SYSTEMS FOR SEVERE CRS AND ICANS AFTER AUTOLOGOUS ANTI‐CD19 CAR T CELLS IN LARGE B‐CELL LYMPHOMA: A DESCAR‐T REGISTRY STUDY FORM THE LYSA.
13. Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA)
14. JAK-STAT PATHWAY AND EPIGENETIC REGULATORS ARE CRITICAL PLAYERS IN BI-ALCL PATHOGENESIS?
15. PS1410 DARATUMUMAB IS WELL TOLERATED AND INDUCES A RAPID HEMATOLOGICAL RESPONSE IN NON IG-M LIGHT CHAIN AMYLOIDOSIS WITH SEVERE CARDIAC IMPAIRMENT
16. CLINICAL, IMMUNOPHENOTYPIC AND GENETIC CHARACTERISTICS OF AGGRESSIVE (NON-BURKITT) B-CELL LYMPHOMA IN A REAL LIFE COHORT
17. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin
18. P114 Treatment of lower risk MDS with del 5q by lenalidomide (LEN), with or without G-CSF: current results of the French Patient Named Program (ATU)
19. Don't Judge a Book by its Cover. 'Steroid Acne': an unrecognized role of Malassezia and Demodex?
20. STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA
21. Caractéristiques clinicobiologiques, facteurs pronostiques et prise en charge thérapeutique du scléromyxœdème : étude rétrospective multicentrique
22. Treatment with anti CD19 CAR‐T cells is safe and effective in patients with relapsed refractory large B‐cell lymphoma with active central nervous system involvement.
23. Cerebral toxoplasmosis in acquired immuno deficiency syndrome: A comparative assisted tomographic and neuropathological study of a case
24. Les agrypnies
25. Tumeur cutanée rapidement évolutive du bras révélant un lymphome de Burkitt
26. Angioimmunoblastic T-cell lymphoma is the most common T-cell lymphoma in two distinct French information data sets
27. AsrR Is an Oxidative Stress Sensing Regulator Modulating Enterococcus faecium Opportunistic Traits, Antimicrobial Resistance, and Pathogenicity
28. Treatment with lenalidomide does not appear to increase the risk of progression in lower risk myelodysplastic syndromes with 5q deletion. A comparative analysis by the Groupe Francophone des Myelodysplasies
29. Nonlinear IBVS controller for the flare maneuver of fixed-wing aircraft using optical flow.
30. Image-based visual servo control for circular trajectories for a fixed-wing aircraft.
31. Visual servoing of a VTOL vehicle using virtual states.
32. Adaptive filtering and image based visual servo control of a ducted fan flying robot.
33. Isolated ischaemia of the spinal cord due to bilateral vertebral artery dissection
34. Navelbine (NVB), and fractionated dose doxorubicin (DX) improves first line advanced breast cancer (ABC) chemotherapy. An overview of 3 phase II trials
35. A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC
36. 157 Phase II trial of vinorelbine (NVB) and cisplatin (CDDP) in stage III–IV non-small cell lung cancer (NSCLC)
37. 1 Phase II trial of navelbine (NVB), in small cell lung cancer (SCLC)
38. FIRST RESULTS OF DLBCL PATIENTS TREATED WITH CAR‐T CELLS AND ENROLLED IN DESCAR‐T REGISTRY, A FRENCH REAL‐LIFE DATABASE FOR CAR‐T CELLS IN HEMATOLOGIC MALIGNANCIES.
39. BRENTUXIMAB VEDOTIN AS CONSOLIDATION TREATMENT IN PATIENTS WITH STAGE I/II CLASSICAL HODGKIN'S LYMPHOMA AND A POSITIVE FDG‐PET AFTER 2 CYCLES OF ABVD: A LYSA PHASE 2 STUDY.
40. Les agrypnies
41. Potentiels évoqués auditifs précoces et de latence moyenne dans les accidents vasculaires vertébrobasilaires
42. « Acné » cortico-induite : rôle prépondérant de Malasseziaet de Demodex ?
43. 1066 - A feasibility study of vinorelbine (VNR) and gemcitabine (GEM) in inoperable stage IIIb-IV NSCLC
44. 649 - Navelbine (NVB), and fractionated dose doxorubicin (DX) improves first line advanced breast cancer (ABC) chemotherapy. An overview of 3 phase II trials
45. 63 Navelbine (NVB), and fractionated doses of cisplatin (CDDP) — 20 mg/m 2/5 days — in the management of advanced non-small cell lung cancer: An overview of 3 phase II trials
46. A phase II study of navelbine ® (NVB) and cisplatin (CDDP) in advanced non-small cell lung cancer stage IIIb–IV (NSCLC): interim results
47. A phase II study of navelbine ® (NVB) and cisplatin (CDDP) in advanced non-small cell lung cancer stage IIIb-IV (NSCLC): interim results
48. Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry.
49. Brexucabtagene autoleucel in relapsed or refractory mantle cell lymphoma, intention-to-treat use in the DESCAR-T registry.
50. Novel prognostic scoring systems for severe CRS and ICANS after anti-CD19 CAR T cells in large B-cell lymphoma.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.